Phibro Animal Health (PAHC) Tops Q2 EPS by 11c ; Offers Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.54, $0.11 better than the analyst estimate of $0.43. Revenue for the quarter came in at $309.3 million versus the consensus estimate of $287.13 million.

GUIDANCE:

Phibro Animal Health sees Q3 2025 EPS of $1.87-$2.01, versus the consensus of $1.71. Phibro Animal Health sees Q3 2025 revenue of $1.25-1.3 billion, versus the consensus of $1.32 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Occidental Petroleum releases Q2 2026 earnings considerations
• Nippon Paint Said To Offer $8.6 Billion For Akzo's Paint Arm - Bloomberg
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'